Cero Therapeutics Holdings Files 8-K
Ticker: CEROW · Form: 8-K · Filed: May 8, 2025 · CIK: 1870404
Sentiment: neutral
Topics: 8-k, corporate-events, financials
TL;DR
Cero Therapeutics filed an 8-K on May 7th, expect updates on financials/operations.
AI Summary
Cero Therapeutics Holdings, Inc. filed an 8-K on May 8, 2025, reporting on events as of May 7, 2025. The filing indicates a change in the company's structure or operations, as it lists "Other Events" and "Financial Statements and Exhibits" as items of disclosure. The company, formerly known as Phoenix Biotech Acquisition Corp., is incorporated in Delaware and operates in the Biological Products sector.
Why It Matters
This 8-K filing signals that Cero Therapeutics Holdings, Inc. has made significant disclosures regarding its business operations or financial status, requiring investor attention.
Risk Assessment
Risk Level: medium — 8-K filings can indicate significant corporate events, but the specific nature of these events requires further analysis to determine the precise risk level.
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- Phoenix Biotech Acquisition Corp. (company) — Former company name
- May 7, 2025 (date) — Earliest event reported date
- May 8, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific "Other Events" are being reported by Cero Therapeutics Holdings, Inc. in this 8-K filing?
The filing lists "Other Events" as an item of disclosure but does not provide specific details within the provided text.
What is the significance of the "Financial Statements and Exhibits" being filed?
The filing of "Financial Statements and Exhibits" suggests that there are material financial updates or supporting documents being provided to the SEC.
When did Cero Therapeutics Holdings, Inc. change its name from Phoenix Biotech Acquisition Corp.?
The date of the name change from Phoenix Biotech Acquisition Corp. to Cero Therapeutics Holdings, Inc. was June 30, 2021.
What is Cero Therapeutics Holdings, Inc.'s Standard Industrial Classification (SIC) code and industry?
Cero Therapeutics Holdings, Inc. has a SIC code of 2836 and is classified under Biological Products (No Diagnostic Substances).
What is the business address and phone number for Cero Therapeutics Holdings, Inc.?
The business address is 201 Haskins Way, Suite 230, South San Francisco, CA 94080, and the business phone number is 650-407-2376.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).